Literature DB >> 29636362

Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFβ Signaling.

Cassandra Ringuette Goulet1,2,3, Geneviève Bernard1,2, Sarah Tremblay1, Stéphane Chabaud1,2, Stéphane Bolduc1,2, Frédéric Pouliot4,3.   

Abstract

A particularly important tumor microenvironment relationship exists between cancer cells and surrounding stromal cells. Fibroblasts, in response to cancer cells, become activated and exhibit myofibroblastic characteristics that favor invasive growth and metastasis. However, the mechanism by which cancer cells promote activation of healthy fibroblasts into cancer-associated fibroblasts (CAF) is still not well understood. Exosomes are nanometer-sized vesicles that shuttle proteins and nucleic acids between cells to establish intercellular communication. Here, bladder cancer-derived exosomes were investigated to determine their role in the activation of healthy primary vesical fibroblasts. Exosomes released by bladder cancer cells are internalized by fibroblasts and promoted the proliferation and expression of CAF markers. In addition, cancer cell-derived exosomes contain TGFβ and in exosome-induced CAFs SMAD-dependent signaling is activated. Furthermore, TGFβ inhibitors attenuated CAF marker expression in healthy fibroblasts. Therefore, these data demonstrate that bladder cancer cells trigger the differentiation of fibroblasts to CAFs by exosomes-mediated TGFβ transfer and SMAD pathway activation. Finally, exosomal TGFβ localized inside the vesicle and contributes 53.4% to 86.3% of the total TGFβ present in the cancer cell supernatant. This study highlights a new function for bladder cancer exosomes as novel modulators of stromal cell differentiation.Implication: This study identifies exosomal TGFβ as new molecular mechanism involved in cancer-associated fibroblast activation. Mol Cancer Res; 16(7); 1196-204. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29636362     DOI: 10.1158/1541-7786.MCR-17-0784

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  80 in total

Review 1.  Cancer Metabolism Drives a Stromal Regenerative Response.

Authors:  Simon Schwörer; Santosha A Vardhana; Craig B Thompson
Journal:  Cell Metab       Date:  2019-02-14       Impact factor: 27.287

2.  Melanoma-derived exosomes induce reprogramming fibroblasts into cancer-associated fibroblasts via Gm26809 delivery.

Authors:  Tairan Hu; Jiacai Hu
Journal:  Cell Cycle       Date:  2019-09-23       Impact factor: 4.534

Review 3.  Tumor-derived exosomes, microRNAs, and cancer immune suppression.

Authors:  Michael W Graner; Sathya Schnell; Michael R Olin
Journal:  Semin Immunopathol       Date:  2018-06-04       Impact factor: 9.623

Review 4.  Extracellular vesicles in urological malignancies: an update.

Authors:  Johannes Linxweiler; Kerstin Junker
Journal:  Nat Rev Urol       Date:  2019-12-11       Impact factor: 14.432

Review 5.  Cancer-associated fibroblasts: overview, progress, challenges, and directions.

Authors:  Qinrong Ping; Ruping Yan; Xin Cheng; Wenju Wang; Yiming Zhong; Zongliu Hou; Yunqiang Shi; Chunhui Wang; Ruhong Li
Journal:  Cancer Gene Ther       Date:  2021-03-12       Impact factor: 5.987

6.  Exosomes in bladder cancer: novel biomarkers and targets.

Authors:  Hao Geng; Qingchen Zhou; Wenhao Guo; Ling Lu; Liangkuan Bi; Yi Wang; Jie Min; Dexin Yu; Zhaofeng Liang
Journal:  J Zhejiang Univ Sci B       Date:  2021-05-15       Impact factor: 3.066

7.  Stromal-Derived Extracellular Vesicles Suppress Proliferation of Bone Metastatic Cancer Cells Mediated by ERK2.

Authors:  Alison B Shupp; Manish Neupane; Lebaron C Agostini; Gang Ning; Jonathan R Brody; Karen M Bussard
Journal:  Mol Cancer Res       Date:  2021-05-21       Impact factor: 5.852

Review 8.  Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.

Authors:  Alphonse E Sirica; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Adv Cancer Res       Date:  2020-12-09       Impact factor: 6.242

Review 9.  Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.

Authors:  Fanglong Wu; Jin Yang; Junjiang Liu; Ye Wang; Jingtian Mu; Qingxiang Zeng; Shuzhi Deng; Hongmei Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-06-10

Review 10.  TGFβ-Directed Therapeutics: 2020.

Authors:  Beverly A Teicher
Journal:  Pharmacol Ther       Date:  2020-08-21       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.